[FULC] QoQ Quarter Result on 30-Sep-2019 [#Q2]

Stock
[FULC] Fulcrum Therapeutics, Inc.
Announcement Date
14-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q2]
Profit Trend
QoQ- -25.61%
YoY- -84.97%
Quarter Report
FULC's Result
FULC's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 2,000 750 0 0 0 0 0 -
PBT -15,685 -18,452 -16,123 -16,542 -13,169 -36,843 -8,859 46.40%
Tax 0 0 -879 -457 -317 -377 -385 -
NP -15,685 -18,452 -16,123 -16,542 -13,169 -36,843 -8,859 46.40%
Tax Rate - - - - - - - -
Total Cost 17,685 19,202 16,123 16,542 13,169 36,843 8,859 58.60%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -784.25 -2,460.27 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.66 -0.81 -0.71 -0.93 -0.56 -1.58 -0.52 17.24%
EPS Diluted -0.66 -0.81 -0.71 -0.93 -0.56 -1.58 -0.52 17.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.